Propafenone Hydrochloride Capsule, Extended Release
Product Images NDC 16714-825

5 FDA label images from Northstar Rx Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Propafenone Hydrochloride (NDC 16714-825). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of propafenone hydrochloride, showing its molecular composition including aromatic rings, hydroxyl group, and hydrochloride moiety.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A Kaplan-Meier survival curve chart showing the proportion of patients without events over time (days) for propafenone hydrochloride extended-release capsules at 225 mg, 325 mg, and 425 mg doses compared to placebo. The graph includes statistical significance values (p values) and a risk table indicating the number of patients at risk at various time points.*
FDA Label Image

225mg60s.jpg (225mg60s)

225mg60s.jpg (225mg60s)
Label for Propafenone Hydrochloride Extended-Release Capsules, USP 225 mg, containing 60 capsules. The label indicates it is a prescription drug by NorthStar Rx LLC. Storage instructions and manufacturer details, including Northstar Rx LLC, Glenmark Pharmaceuticals Limited, and NorthStar Healthcare UC, are also present along with an expiration date of 12/2025.*
FDA Label Image

325mg60s.jpg (325mg60s)

325mg60s.jpg (325mg60s)
Propafenone Hydrochloride Extended-Release Capsules, USP 325 mg label for a 60-capsule bottle by Northstar Rx LLC. The label includes dosage form, strength, quantity, storage instructions, manufacturer details, and barcode. The label indicates prescription use only and specifies to dispense in a tight container.*
FDA Label Image

425mg60s.jpg (425mg60s)

425mg60s.jpg (425mg60s)
Label for Propafenone Hydrochloride Extended-Release Capsules, USP 425 mg by NorthStar Rx LLC. The carton indicates 60 capsules per bottle. It includes dosing and storage information, manufacturer details, and displays the NDC 16714-827-01. The label features the NorthStar logo and specifies this is an Rx-only human prescription drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.